Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I

Ruoxing Wang1, Jundi Wang1, Dhiraj Acharya1

  • 1From the Departments of Biological Sciences and.

Insights

Mouse embryonic stem cells (mESCs) do not produce type I interferons (IFNs) but can respond to them. This study reveals unique properties of mESCs in innate immunity and stem cell physiology.

Area of Science:

  • Immunology
  • Developmental Biology
  • Stem Cell Biology

Background:

  • Mouse embryonic stem cells (mESCs) were previously found deficient in type I interferon (IFN) expression upon viral stimulation.
  • Understanding the innate immune response in stem cells is crucial for developmental biology and regenerative medicine.

Purpose of the Study:

  • To investigate the responsiveness of mESCs to type I IFNs.
  • To determine if mESCs can mediate antiviral effects.
  • To assess the impact of type I IFNs on the stem cell state.

Main Methods:

  • Stimulation of mESCs with type I IFNs.
  • Analysis of IFN-stimulated gene expression.
  • Assessment of antiviral activity against La Crosse virus and chikungunya virus.
  • Evaluation of stem cell marker expression.

Main Results:

  • mESCs express key IFN pathway signaling components.
  • mESCs respond to type I IFNs by expressing IFN-stimulated genes and mediating antiviral effects.
  • mESCs exhibit weaker IFN responses compared to fibroblasts.
  • Type I IFNs do not alter the stem cell state of mESCs.

Conclusions:

  • mESCs are deficient in type I IFN expression but possess functional IFN response pathways.
  • mESCs can respond to type I IFNs, exhibiting antiviral activity without compromising their stem cell identity.
  • These findings highlight unique characteristics of mESCs relevant to innate immunity and stem cell biology.